Magic mushroom compound tested for stroke patients
NCT ID NCT07053917
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether psilocybin, a psychedelic substance, is safe for people who had a stroke at least a year ago. Researchers will monitor blood pressure and other vital signs in 20 participants. The goal is to see if psilocybin can help with lingering symptoms like weakness or paralysis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Johns Hopkins
RECRUITINGBaltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a metronome beat retrain the brain after a stroke?
- Digital peer support may ease long-term stroke recovery for younger survivors
- Can juggling two tasks at once help stroke survivors walk better?
- Slow breaths, faster recovery? a trial tests breathing and neck release after stroke
- Robots vs. therapists: a head-to-head trial for stroke recovery
- Stroke recovery from home: can video-based motor training outperform standard physical therapy?